Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postgenome-based Systemic Discovery of Strong Biomarkers Predict Gastric Cancer Chemotherapy Response

NCT03253107 is registered in ClinicalTrials.gov with Kyungpook National University Hospital as lead sponsor.

NCT NCT03253107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03253107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postgenome-based Systemic Discovery of Strong Biomarkers Predict Gastric Cancer Chemotherapy Response
Lead sponsor
Kyungpook National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2015
Completion date
December 31, 2024
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, gastric cancer, predictive cancer model